The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non-wearable monitor.


Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
12 2021
Historique:
revised: 08 10 2021
received: 26 07 2021
accepted: 09 10 2021
pubmed: 1 12 2021
medline: 18 3 2022
entrez: 30 11 2021
Statut: ppublish

Résumé

The aim of this study was to examine the following by using a non-wearable monitor: (ⅰ) the trajectory of vital signs (VS) in the last 2 weeks of life among cancer patients, and (ⅱ) the difference in change over time of VS between cancer patients with and without opioid use. We conducted a longitudinal study involving cancer patients in a palliative care unit (PCU) from April 2018 to October 2019. VS were collected continuously using a non-wearable monitor, and we calculated the means of respiratory rate (RR) and heart rate (HR) per hour, and counts of apnea per hour as outcome variables. Explanatory variables were time (subtracting time of death from measurement time of VS, divided by 36) and opioid use. Mean difference (MD) of time represented the slope per hour of VS values. First, we analyzed the associations between VS per hour and time using a linear mixed model (LMM) with random intercepts and slope over time. Second, we analyzed the associations between VS and interaction term between time and opioid use. We analyzed 26 cancer patients. RR (MD: 0.27 beats/min [95% CI: 0.27-0.28]), HR (MD: 1.51 beats/min [95% CI: 1.50-1.52]), and apnea (MD: 0.71 count/hour [95% CI: 0.70-0.72]) significantly increased hourly. In addition, RR was significantly associated with interaction term (MD: -1.59 beats/min [95% CI: -3.11 to -0.07]), which indicates that there is a difference in the slope of RR between opioid users and non-users. We have successfully described the trajectory of VS in high-resolution under conditions of a natural end of life in PCU.

Identifiants

pubmed: 34845870
doi: 10.1002/cam4.4382
pmc: PMC8683542
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8799-8807

Informations de copyright

© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Références

Cancer Med. 2021 Dec;10(24):8799-8807
pubmed: 34845870
Stat Med. 2013 Jul 10;32(15):2585-94
pubmed: 23242852
J Formos Med Assoc. 2009 Mar;108(3):231-9
pubmed: 19293039
Support Care Cancer. 2019 Jun;27(6):1973-1984
pubmed: 30863893
J Palliat Med. 2021 Nov;24(11):1634-1640
pubmed: 33733880
J Pain Symptom Manage. 2015 Apr;49(4):690-6
pubmed: 25261639
J Pain Symptom Manage. 1990 Apr;5(2):83-93
pubmed: 2348092
PLoS One. 2019 Jan 15;14(1):e0210875
pubmed: 30645637
Future Oncol. 2017 Apr;13(9):833-841
pubmed: 27875910
J Pain Symptom Manage. 2014 Oct;48(4):510-7
pubmed: 24731412
Drug Discov Ther. 2017;11(3):126-132
pubmed: 28757513
Support Care Cancer. 1999 May;7(3):128-33
pubmed: 10335930
J Physiol Anthropol. 2011;30(3):103-9
pubmed: 21636953

Auteurs

Haruka Tanaka (H)

Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Integrated Health Sciences, Graduate School of Medicine, Nagoya University, Aichi, Japan.

Sakiko Fukui (S)

Graduate School of Medicine, Osaka University, Osaka, Japan.
Graduate School of Health Science, Tokyo Medical and Dental University, Tokyo, Japan.

Isseki Maeda (I)

Department of Palliative Care, Senri-Chuo Hospital, Osaka, Japan.

Yutaka Hatano (Y)

Department of Palliative Care, Daini Kyoritsu Hospital, Hyogo, Japan.

Akari Higuchi (A)

Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Yoko Higami (Y)

Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Nursing, Osaka Medical and Pharmaceutical University, Osaka, Japan.

Miyae Yamakawa (M)

Graduate School of Medicine, Osaka University, Osaka, Japan.

Momoe Utsumi (M)

Graduate School of Medicine, Osaka University, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH